LFCM
RXDX

Long Focus Capital Management’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Long Focus Capital Management’s Portfolio RXDX Stock Details RXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-35,000
Closed -$988K – 110
2022
Q2 		$988K Buy
+35,000
New +$988K 0.1% 73
2022
Q1 		– Sell
-16,824
Closed -$665K – 109
2021
Q4 		$665K Buy
+16,824
New +$665K 0.09% 71